Alex F. Herrera
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment 178
- Oncology top 1%
- CAR-T cell therapy research 115
- Cancer Immunotherapy and Biomarkers 35
- Viral-associated cancers and disorders 25
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research 54
- Neurology top 2%
- CNS Lymphoma Diagnosis and Treatment 25
- Immunology top 5%
-
- Cutaneous lymphoproliferative disorders research 18
-
- Lung Cancer Treatments and Mutations 16
- Co-authors
- Laurie H. SehnChristopher R. FlowersMatthew J. MatasarMuhıt ÖzcanTae Min KimAndrew McMillanGrace KuMark Hertzberg
- Journals
- New England Journal of Medicine (1 paper)Nature Medicine (1 paper)Journal of Clinical Oncology (21 papers)
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
Alex F. Herrera
216 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Pathology and Forensic Medicine 2.1k
- Oncology 2.5k
- Genetics 587
- Neurology 554
- Immunology 642
Countries citing papers authored by Alex F. Herrera
This map shows the geographic impact of Alex F. Herrera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex F. Herrera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex F. Herrera more than expected).
Fields of papers citing papers by Alex F. Herrera
This network shows the impact of papers produced by Alex F. Herrera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex F. Herrera. The network helps show where Alex F. Herrera may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alex F. Herrera, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 6 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 1 | |
| 9 | 2023 | 11 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 1 | |
| 12 | 2022 | 21 | |
| 13 | 2022 | 11 | |
| 14 | 2021 | 107 | |
| 15 | 2021 | 29 | |
| 16 | 2021 | 3 | |
| 17 | 2020 | 14 | |
| 18 | 2019 | 61 | |
| 19 | 2019 | 72 | |
| 20 | 2017 | 230 |
About Alex F. Herrera
Alex F. Herrera is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics, having authored 239 papers that have together received 3.5k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (178 papers), CAR-T cell therapy research (115 papers), Chronic Lymphocytic Leukemia Research (54 papers), Cancer Immunotherapy and Biomarkers (35 papers), CNS Lymphoma Diagnosis and Treatment (25 papers), Viral-associated cancers and disorders (25 papers), Cutaneous lymphoproliferative disorders research (18 papers) and Lung Cancer Treatments and Mutations (16 papers). The work is most often cited by research in Pathology and Forensic Medicine (2.1k citations), Oncology (2.5k citations) and Genetics (587 citations). Alex F. Herrera has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Laurie H. Sehn, Christopher R. Flowers, Matthew J. Matasar, Muhıt Özcan, Tae Min Kim, Andrew McMillan, Grace Ku, Mark Hertzberg, Jamie Hirata and Nancy L. Bartlett. Their work appears in journals such as New England Journal of Medicine, Nature Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.